- Written by ClinicalTrials.gov
- Category: Joint Diseases
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: DMARD
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified September 2013
- Details
Improving orthopaedic care, education and research using Internet technologies
© 1999-2017 Orthogate. All rights reserved.